Skip to main content
. 2021 Sep 24;71(5):1063–1074. doi: 10.1007/s00262-021-03060-w

Fig. 5.

Fig. 5

Kaplan–Meier analysis of overall and progression-free survival stratified by alpha fetoprotein concentrations. a Overall survival among patients with ≥ 400 ng/mL; b progression-free survival among patients with ≥ 400 ng/mL; c overall survival among patients with < 400 ng/mL; and d progression-free survival among patients with < 400 ng/mL. HR hazard ratio, ICIs immune checkpoint inhibitors, Len lenvatinib, OS overall survival, PFS progression-free survival